Literature DB >> 19526459

The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription.

Chao-Kai Chou1, Dung-Fang Lee, Hui-Lung Sun, Long-Yuan Li, Chun-Yi Lin, Wei-Chien Huang, Jung-Mao Hsu, Hsu-Ping Kuo, Hirohito Yamaguchi, Ying-Nai Wang, Mo Liu, Hsin-Yi Wu, Pao-Chi Liao, Chia-Jui Yen, Mien-Chie Hung.   

Abstract

MAX dimerization protein 1 (MAD1) is a transcription suppressor that antagonizes MYC-mediated transcription activation, and the inhibition mechanism occurs mainly through the competition of target genes' promoter MYC binding sites by MAD1. The promoter binding proteins switch between MYC and MAD1 affects cell proliferation and differentiation. However, little is known about MAD1's regulation process in cancer cells. Here, we present evidence that AKT inhibits MAD1-mediated transcription repression by physical interaction with and phosphorylation of MAD1. Phosphorylation reduces the binding affinity between MAD1 and its target genes' promoter and thereby abolishes its transcription suppression function. Mutation of the phosphorylation site from serine to alanine rescues the DNA-binding ability in the presence of activated AKT. In addition, AKT inhibits MAD1-mediated target genes (hTERT and ODC) transcription repression and promotes cell cycle and cell growth. However, mutated S145A MAD1 abrogates the inhibition by AKT. Thus, our results suggest that phosphorylation of MAD1 by AKT inhibits MAD1-mediated transcription suppression and subsequently activates the transcription of MAD1 target genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19526459      PMCID: PMC2783450          DOI: 10.1002/mc.20557

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  27 in total

1.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

Review 2.  Transcriptional activation by the Myc oncoprotein.

Authors:  M D Cole; M A Nikiforov
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 3.  Signaling intricacies take center stage in cancer cells.

Authors:  Rakesh Kumar; Mien-Chie Hung
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

Review 4.  Structural aspects of interactions within the Myc/Max/Mad network.

Authors:  S K Nair; S K Burley
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 5.  The Mad side of the Max network: antagonizing the function of Myc and more.

Authors:  S Rottmann; B Lüscher
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 6.  Transcriptional regulation and transformation by Myc proteins.

Authors:  Sovana Adhikary; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

Review 7.  Regulated expression and function of the c-Myc antagonist, Mad1, during a molecular switch from proliferation to differentiation.

Authors:  C M Cultraro; T Bino; S Segal
Journal:  Curr Top Microbiol Immunol       Date:  1997       Impact factor: 4.291

Review 8.  Mechanisms and consequences of activation of protein kinase B/Akt.

Authors:  J Downward
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

9.  Expression of Mad1 protein inhibits proliferation of cancer cells and inversely correlated with Myc protein expression in primary gastric cancer.

Authors:  S Han; K Park; H Y Kim; M S Lee; H J Kim; Y D Kim
Journal:  Oncol Rep       Date:  1999 May-Jun       Impact factor: 3.906

10.  Mad proteins contain a dominant transcription repression domain.

Authors:  D E Ayer; C D Laherty; Q A Lawrence; A P Armstrong; R N Eisenman
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more
  13 in total

1.  Getting MAD at MYC.

Authors:  Maria Letizia Giardino Torchia; Jonathan D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-10       Impact factor: 11.205

2.  Adenovirus 5 E1A enhances histone deacetylase inhibitors-induced apoptosis through Egr-1-mediated Bim upregulation.

Authors:  H Yamaguchi; C-T Chen; C-K Chou; A Pal; W Bornmann; G N Hortobagyi; M-C Hung
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

Review 3.  Regulation of the human catalytic subunit of telomerase (hTERT).

Authors:  Michael Daniel; Gregory W Peek; Trygve O Tollefsbol
Journal:  Gene       Date:  2012-02-13       Impact factor: 3.688

4.  Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells.

Authors:  Wei-Chien Huang; Yun-Ju Chen; Long-Yuan Li; Ya-Ling Wei; Sheng-Chieh Hsu; Shing-Ling Tsai; Pei-Chun Chiu; Wei-Pang Huang; Ying-Nai Wang; Chung-Hsuan Chen; Wei-Chao Chang; Wen-Chang Chang; Andy Jer-En Chen; Chang-Hai Tsai; Mien-Chie Hung
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

5.  Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.

Authors:  Gregory W Peek; Trygve O Tollefsbol
Journal:  Exp Cell Res       Date:  2016-03-23       Impact factor: 3.905

Review 6.  Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

7.  Amplitude modulation of androgen signaling by c-MYC.

Authors:  Min Ni; Yiwen Chen; Teng Fei; Dan Li; Elgene Lim; X Shirley Liu; Myles Brown
Journal:  Genes Dev       Date:  2013-03-25       Impact factor: 11.361

8.  The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention.

Authors:  Gregory W Peek; Trygve O Tollefsbol
Journal:  Clin Epigenetics       Date:  2011-01-26       Impact factor: 6.551

Review 9.  Therapeutic targeting of replicative immortality.

Authors:  Paul Yaswen; Karen L MacKenzie; W Nicol Keith; Patricia Hentosh; Francis Rodier; Jiyue Zhu; Gary L Firestone; Ander Matheu; Amancio Carnero; Alan Bilsland; Tabetha Sundin; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-04-11       Impact factor: 15.707

Review 10.  Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer.

Authors:  Steffen Heeg
Journal:  Pharmgenomics Pers Med       Date:  2015-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.